Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

63.51
+0.73001.16%
Post-market: 64.110.5961+0.94%19:59 EDT
Volume:1.40M
Turnover:88.73M
Market Cap:6.24B
PE:27.16
High:64.30
Open:63.50
Low:63.02
Close:62.78
Loading ...
Jan 13, 2020

Major Issues Report

Current report, items 2.02, 5.02, 5.03, and 9.01
Dec 23, 2019

Major Issues Report

Current report, items 1.01 and 3.02
Dec 13, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 8.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 11, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 20, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 08, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 07, 2019

Major Issues Report

Current report, item 5.07
May 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 31, 2018

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Jun 08, 2016

[Supp]Public Prospectus

Jun 08, 2016

[Supp]Public Prospectus

自由写作招股说明书
Apr 29, 2016

[Rev.]Annual Report

Apr 29, 2016

[Rev.]Annual Report

FY 2015 ended 12/31/15 – amended